We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+8.37%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$14.6B
AUM Growth
+$1.76B
Cap. Flow
+$1.61B
Cap. Flow %
11.04%
Top 10 Hldgs %
12.14%
Holding
2,182
New
575
Increased
392
Reduced
342
Closed
670

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$126M
2
NVDA icon
NVIDIA
NVDA
+$123M
3
NFLX icon
Netflix
NFLX
+$81.9M
4
MSFT icon
Microsoft
MSFT
+$52.2M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$51M

Sector Composition

Rank Sector Weight
1 Technology 4.6%
2 Consumer Discretionary 2.55%
3 Healthcare 2.5%
4 Communication Services 1.71%
5 Financials 1.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STX icon
376
CALL
Seagate
STX
$193B
$8.26M 0.06%
30,000
DQ
377
CALL
Daqo New Energy
DQ
$790M
$8.23M 0.06%
279,000
-133,300
-32% -$4.07M
MSM icon
378
CALL
MSC Industrial Direct
MSM
$7.02B
$8.2M 0.06%
+97,500
New +$8.45M
MSM icon
379
PUT
MSC Industrial Direct
MSM
$7.02B
$8.2M 0.06%
+97,500
New +$8.45M
TARS icon
380
CALL
Tarsus Pharmaceuticals
TARS
$2.56B
$8.19M 0.06%
100,000
+85,400
+585% +$6.38M
AMGN icon
381
CALL
Amgen
AMGN
$203B
$8.18M 0.06%
+25,000
New +$7.93M
OMER icon
382
CALL
Omeros
OMER
$709M
$8.17M 0.06%
+475,700
New +$4.1M
DD icon
383
DuPont de Nemours
DD
$18.6B
$8.16M 0.06%
67,632
-38,325
-36% -$4.31M
ASTS icon
384
PUT
AST SpaceMobile
ASTS
$16.8B
$8.11M 0.06%
111,600
+30,000
+37% +$2.14M
NFLX icon
385
CALL
Netflix
NFLX
$292B
$8.07M 0.06%
+86,100
New +$9.28M
PHAT icon
386
CALL
Phathom Pharmaceuticals
PHAT
$912M
$8.07M 0.06%
486,300
-513,700
-51% -$7.34M
CBRE icon
387
CALL
CBRE Group
CBRE
$40.8B
$8.04M 0.06%
50,000
OR icon
388
CALL
OR Royalties Inc
OR
$5.47B
$8.03M 0.06%
+226,800
New +$7.95M
RIO icon
389
CALL
Rio Tinto
RIO
$148B
$8.02M 0.06%
100,200
+63,500
+173% +$4.57M
CVS icon
390
PUT
CVS Health
CVS
$137B
$7.94M 0.05%
100,000
-100,000
-50% -$7.88M
ESPR
391
CALL
DELISTED
Esperion Therapeutics
ESPR
$7.93M 0.05%
+2,142,500
New +$6.92M
XPER icon
392
PUT
Xperi
XPER
$365M
$7.86M 0.05%
1,340,600
+684,100
+104% +$4.29M
VKTX icon
393
CALL
Viking Therapeutics
VKTX
$4.04B
$7.77M 0.05%
221,000
-690,900
-76% -$24.5M
MTCH icon
394
CALL
Match Group
MTCH
$8.84B
$7.75M 0.05%
240,000
CLSK icon
395
CALL
CleanSpark
CLSK
$3.73B
$7.72M 0.05%
762,800
+325,000
+74% +$4.87M
BE icon
396
CALL
Bloom Energy
BE
$52.6B
$7.72M 0.05%
88,800
-19,100
-18% -$2.01M
FMX icon
397
PUT
Fomento Económico Mexicano
FMX
$43.3B
$7.67M 0.05%
+75,900
New +$7.37M
UNP icon
398
Union Pacific
UNP
$183B
$7.63M 0.05%
33,000
CEG icon
399
PUT
Constellation Energy
CEG
$98B
$7.63M 0.05%
21,600
EXAS
400
PUT
DELISTED
Exact Sciences
EXAS
$7.62M 0.05%
75,000

Similar funds

Caption Management's Q4 2025 Portfolio in Review

As of Q4 2025, Caption Management held 2,182 positions worth $14.6B, up 14% from $12.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Caption Management deployed $1.61B of net new capital in Q4 2025, opening 575 new positions and adding to 392 existing holdings. Its largest new stake was Apple: 470,000 shares worth $128M.

By sector, the portfolio is most concentrated in Technology at 4.6% of assets, up from 2.7% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Tesla, an estimated $22.2M trimmed.

  • Caption Management's largest Q4 2025 buy was Apple: 470,000 shares worth $128M.
  • Caption Management added most to NVIDIA in Q4 2025, an estimated $123M increase.
  • Caption Management's biggest Q4 2025 reduction was Tesla, cutting an estimated $22.2M.
  • Caption Management fully exited EchoStar in Q4 2025, selling an estimated $34.1M.
  • Caption Management's ten largest holdings make up 12% of its $14.6B portfolio in Q4 2025.
  • Caption Management opened 575 new positions and closed 670 in Q4 2025.
  • Caption Management's portfolio value rose 14% quarter-over-quarter to $14.6B.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.